Liver Directed RT + Chemo-immunotherapy for ES-SCLC
Clinical trial NCT04923776 · TERMINATED
Trial details
- NCT number
- NCT04923776
- Sponsor
- Brian Henick, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-20
- Primary completion
- 2023-09-13
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.